About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Cada episodi de neutropènia febril (NF) que presenta un nen amb càncer durant el seu tractament amb quimioteràpia requereix a) hospitalització, b) tractaments antimicrobians, c) exàmens de laboratori, d) imatges i eventualment e) hospitalització en unitats de pacient crític. És fonamental poder comptar amb un maneig precoç, racional i personalitzat dels episodis de NF, apuntant a tres aspectes fonamentals: una adequada estratificació de risc d'infeccions significatives, una bona presa de decisions per obtenir el millor resultat clínic i una optimització de l'ús de els recursos dels sistemes de salut.
CV: Dra. María Elena Santolaya, Pediatra, Infectòloga, Hospital de nens Dr. Luis Calvo Mackenna, Professora Titular, Facultat de Medicina, Universitat de Xile. Experta en maneig d'infeccions en nens immunocompromesos.
Amfitrions: Dr. Pere Soler Palacín i Dra. Natalia Mendoza, del grup de Recerca Infecció en el pacient pediàtric Immunodeprimit
Format: Presencial de lliure accés i gratuït. Via online: registre https://gencat.zoom.us/j/94629751846#success